Integral Health Asset Management, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Integral Health Asset Management, LLC disclosed 81 US equity positions worth $1.1bn in its Q4 2024 13F filing. The largest position was INSM at 9.5% of the reported book, followed by THC and BSX. Against the Q3 2024 filing, it opened 19 new positions, added to 19 and reduced 9 among the top 50 holdings.
What did Integral Health Asset Management, LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 9.5% | $107.0m | 1,550,000 | 7% | added |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 4.5% | $50.5m | 400,000 | -25% | reduced |
| 3 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 4.3% | $49.1m | 550,000 | 0% | held |
| 4 | VERA VERA THERAPEUTICS INC | Healthcare | 4.3% | $48.6m | 1,150,000 | 130% | added |
| 5 | CYTK CYTOKINETICS INC | Healthcare | 4.2% | $47.0m | 1,000,000 | 33% | added |
| 6 | CNC CENTENE CORP DEL | Healthcare | 2.7% | $30.3m | 500,000 | – | new |
| 7 | CAH CARDINAL HEALTH INC | Healthcare | 2.6% | $29.6m | 250,000 | – | new |
| 8 | LLY ELI LILLY & CO | Healthcare | 2.6% | $29.3m | 38,000 | 280% | added |
| 9 | EHC ENCOMPASS HEALTH CORP | Healthcare | 2.5% | $27.7m | 300,000 | 9% | added |
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.1% | $24.1m | 550,000 | 57% | added |
| 11 | 2655787D BLUEPRINT MEDICINES CORP | 2.1% | $24.0m | 275,000 | -5% | reduced | |
| 12 | CVS CVS HEALTH CORP | Healthcare | 2.0% | $22.4m | 500,000 | – | new |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.9% | $21.8m | 160,000 | – | new |
| 14 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.8% | $20.9m | 40,000 | – | new |
| 15 | MCK MCKESSON CORP | Healthcare | 1.8% | $19.9m | 35,000 | – | new |
| 16 | MRK MERCK & CO INC | Healthcare | 1.8% | $19.9m | 200,000 | 0% | held |
| 17 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 1.8% | $19.8m | 350,000 | 100% | added |
| 18 | DGX QUEST DIAGNOSTICS INC | Healthcare | 1.7% | $19.6m | 130,000 | 8% | added |
| 19 | QURE UNIQURE NV | 1.7% | $19.4m | 1,100,000 | 175% | added | |
| 20 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.7% | $19.4m | 350,000 | -7% | reduced |
| 21 | INSP INSPIRE MED SYS INC | Healthcare | 1.6% | $18.5m | 100,000 | -38% | reduced |
| 22 | GILD GILEAD SCIENCES INC | Healthcare | 1.6% | $18.5m | 200,000 | – | new |
| 23 | NARIUSD INARI MED INC | 1.6% | $17.9m | 350,000 | -12% | reduced | |
| 24 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.4% | $16.2m | 375,000 | 36% | added |
| 25 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 1.4% | $16.2m | 950,000 | 90% | added |
| 26 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.4% | $15.3m | 300,000 | 0% | held | |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.3% | $14.7m | 225,000 | – | new |
| 28 | EWTX EDGEWISE THERAPEUTICS INC | 1.3% | $14.7m | 550,000 | – | new | |
| 29 | JSPR JASPER THERAPEUTICS INC | 1.2% | $13.9m | 650,000 | 86% | added | |
| 30 | FMS FRESENIUS MEDICAL CARE AG | Healthcare | 1.2% | $13.6m | 600,000 | 33% | added |
| 31 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.2% | $13.4m | 420,000 | – | new | |
| 32 | MDT MEDTRONIC PLC | Healthcare | 1.1% | $12.0m | 150,000 | -50% | reduced |
| 33 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.1% | $11.9m | 300,000 | – | new |
| 34 | DXCM DEXCOM INC | Healthcare | 1.0% | $11.7m | 150,000 | 25% | added |
| 35 | BNTX BIONTECH SE | Healthcare | 1.0% | $11.4m | 100,000 | 100% | added |
| 36 | WAT WATERS CORP | Healthcare | 1.0% | $11.1m | 30,000 | – | new |
| 37 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 1.0% | $11.0m | 500,000 | – | new |
| 38 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 1.0% | $10.8m | 200,000 | -9% | reduced |
| 39 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.0% | $10.8m | 875,000 | 146% | added |
| 40 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.9% | $10.7m | 200,000 | – | new |
| 41 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.9% | $10.6m | 45,000 | 80% | added |
| 42 | HUM HUMANA INC | Healthcare | 0.9% | $10.1m | 40,000 | – | new |
| 43 | OSCR OSCAR HEALTH INC | Healthcare | 0.8% | $9.4m | 700,000 | – | new |
| 44 | COO COOPER COS INC | Healthcare | 0.8% | $9.2m | 100,000 | -9% | reduced |
| 45 | KRYS KRYSTAL BIOTECH INC | Healthcare | 0.8% | $8.6m | 55,000 | – | new |
| 46 | EXK EXACT SCIENCES CORP | Basic Materials | 0.7% | $8.4m | 150,000 | 88% | added |
| 47 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.7% | $8.4m | 150,000 | – | new |
| 48 | ETNBGBP 89BIO INC | 0.7% | $7.8m | 1,000,000 | 100% | added | |
| 49 | ACLXGBX ARCELLX INC | 0.7% | $7.7m | 100,000 | -64% | reduced | |
| 50 | TARA PROTARA THERAPEUTICS INC | 0.7% | $7.4m | 1,400,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.